0000945621-13-000323.txt : 20131022 0000945621-13-000323.hdr.sgml : 20131022 20131022170113 ACCESSION NUMBER: 0000945621-13-000323 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20131022 DATE AS OF CHANGE: 20131022 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NOVOGEN LTD CENTRAL INDEX KEY: 0001075880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-50612 FILM NUMBER: 131164151 BUSINESS ADDRESS: STREET 1: LEVEL 1 STREET 2: 16 - 20 EDGEWORTH DAVID AVE CITY: HORNSBY NSW STATE: C3 ZIP: 2077 BUSINESS PHONE: 01161298780088 MAIL ADDRESS: STREET 1: LEVEL 1 STREET 2: 16 - 20 EDGEWORTH DAVID AVE CITY: HORNSBY NSW STATE: C3 ZIP: 2077 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AUSTIN JOSIAH T CENTRAL INDEX KEY: 0000932267 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 4673 CHRISTOPHER PLACE CITY: DALLAS STATE: TX ZIP: 75204 SC 13D/A 1 nvgnamendmentno11.htm AMENDMENT NO. 11 TO SCHEDULE 13D nvgnamendmentno11.htm

SCHEDULE 13D

CUSIP NO. 67010F202
  
PAGE 1 OF 5 PAGES



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D


Under the Securities Exchange Act of 1934
(Amendment No. 11)


NOVOGEN LIMITED
____________________________________________________________________________________
(Name of Issuer)
 
Common Stock
____________________________________________________________________________________
(Title of Class of Securities)
 
67010F202
 
_______________________________________________________
 
(CUSIP Number)
 
David J. Harris, Esq., 1900 K Street, N.W. Washington, D.C.  20006 (202) 261-3385
____________________________________________________________________________________
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
October 15, 2013
 
______________________________________________________
 
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box .
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 

 
 
 
 

SCHEDULE 13D

CUSIP NO. 67010F202
  
PAGE 2 OF 5 PAGES

1
NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Josiah T. Austin
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                                      (a)             (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
 NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
7
SOLE VOTING POWER
 
0
 
 
8
SHARED VOTING POWER
 
17,935,908 Ordinary Shares (4,531,633 of which are directly owned Ordinary Shares with the remaining 13,404,275 represented by 536,171 Sponsored ADRs)
 
 
9
SOLE DISPOSITIVE POWER
 
0
 
 
10
SHARED DISPOSITIVE POWER
 
17,935,908 Ordinary Shares (4,531,633 of which are directly owned Ordinary Shares with the remaining 13,404,275 represented by 536,171 Sponsored ADRs)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
17,935,908 Ordinary Shares (4,531,633 of which are directly owned Ordinary Shares with the remaining 13,404,275 represented by 536,171 Sponsored ADRs)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES) 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.44%
14
TYPE OF REPORTING PERSON
IN


 
 
 
 

SCHEDULE 13D

CUSIP NO. 67010F202
  
PAGE 3 OF 5 PAGES

1
NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
El Coronado Holdings, L.L.C.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                                      (a)  (b) x
3
SEC USE ONLY
 
4
SOURCE OF FUNDS
WC
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)                               
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Arizona
 NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
7
SOLE VOTING POWER
 
0
 
 
8
SHARED VOTING POWER
 
17,935,908 Ordinary Shares (4,531,633 of which are directly owned Ordinary Shares with the remaining 13,404,275 represented by 536,171 Sponsored ADRs)
 
 
9
SOLE DISPOSITIVE POWER
 
0
 
 
10
SHARED DISPOSITIVE POWER
 
17,935,908 Ordinary Shares (4,531,633 of which are directly owned Ordinary Shares with the remaining 13,404,275 represented by 536,171 Sponsored ADRs)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
17,935,908 Ordinary Shares (4,531,633 of which are directly owned Ordinary Shares with the remaining 13,404,275 represented by 536,171 Sponsored ADRs)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES                                                     
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.44%
14
TYPE OF REPORTING PERSON
HC


 
 
 
 

SCHEDULE 13D

CUSIP NO. 67010F202
  
PAGE 4 OF 5 PAGES


ITEM 1.                      Security and Issuer

This Amendment No. 11 to the Statement on Schedule 13D heretofore filed on November 18, 2004 is filed with respect to the ordinary shares of common stock (“Ordinary Shares”) of Novogen Limited (the “Company”).  The address of the Company is 1-7 Waterloo Road, Macquarie Park, NSW, Australia.  The Statement is being filed on behalf of Josiah T. Austin, a United States Citizen, and El Coronado Holdings, L.L.C. (“ECH”), an Arizona limited liability company whose principal place of business is 4673 Christopher Place, Dallas, Texas 75204 (collectively, the “Reporting Persons”) to reflect the following amendments to Item 3, Item 4 and Item 5.

ITEM 3.                      Source and Amount of Funds or Other Consideration

Since March 7, 2013, the Reporting Persons have sold 90,025 Sponsored ADRs (representing 2,250,625 Ordinary Shares) for an aggregate consideration (exclusive of brokers’ commissions) of $559,208.29.

All dollar amounts are in U.S. dollars.

ITEM 4.                      Purpose of Transaction

Austin, as sole Managing Member of ECH is filing this Amendment No. 11 to the Statement on Schedule 13D because he is deemed beneficial owner of more than 5% of the Company's Ordinary Shares.  Austin, as sole Managing Member of ECH, will continually evaluate the business, financial conditions, and prospects of the Company, as well as conditions in the economy and the pharmaceutical industry in general, with a view toward determining whether to hold, decrease, or from time to time add to these investments in Ordinary Shares and Sponsored ADRs.  The sales to which this Amendment No. 11 relate were made by Austin solely for estate planning purposes.  Austin, as sole Managing Member of ECH, has no present plans or intent to make proposals which relate to or would result in any action enumerated from subparagraph (b) through subparagraph (j) of Item 4 of Schedule 13D.

ITEM 5.                      Interest in Securities of the Issuer

(a)           Austin is deemed beneficial owner of 17,935,908 Ordinary Shares (4,531,633 of which are directly owned Ordinary Shares with the remaining 13,404,275 Ordinary Shares represented by 536,171 Sponsored ADRs) as sole Managing Member of ECH.  ECH is deemed beneficial owner of 17,935,908 Ordinary Shares (4,531,633 of which are directly owned Ordinary Shares with the remaining 13,404,275 represented by 536,171 Sponsored ADRs).  Based on the 144,208,463 Ordinary Shares outstanding as of October 4, 2013 as reported on the Company’s 6-K filed on October 9, 2013, Austin and ECH’s deemed beneficial holdings each represent 12.44% of the Company’s Ordinary Shares.

 
 
 
 

SCHEDULE 13D

CUSIP NO. 67010F202
  
PAGE 5 OF 5 PAGES


(b)           As the sole Managing Member of ECH, Austin shares with ECH the power to vote or to direct the vote or to dispose or to direct the disposition of the 17,935,908 Ordinary Shares (4,531,633 of which are directly owned Ordinary Shares with the remaining 13,404,275 represented by 536,171 Sponsored ADRs) held by ECH.

(c)           No transactions in the Company’s Sponsored ADRs or Ordinary Shares have been effected by the Reporting Persons during the last 60 days except the following transactions, which were open market transactions.  Where applicable, prices do not include brokerage fees.

Reporting Person
Transaction
Date
Quantity
Price Per Unit
Austin, on behalf of ECH
Sale of Sponsored ADRs
10/15/2013
90,025
$6.2117


(d)           No person other than the Reporting Persons has any right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, such securities.

(e)           Not Applicable.


SIGNATURE

After reasonable inquiry and to the best knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.


Date: October 22, 2013
   /s/ Josiah T. Austin
   
Josiah T. Austin,
   
Individually and as Sole Managing Member of ECH